LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

The safety of chronic antithrombotic therapy in patients with factor XI deficiency

Photo from wikipedia

Dunleavy, K., Pittaluga, S., Maeda, L.S., Advani, R., Chen, C.C., Hessler, J., Steinberg, S.M., Grant, C., Wright, G., Varma, G., Staudt, L.M., Jaffe, E.S. & Wilson, W.H. (2013) Dose-adjusted EPOCH-rituximab… Click to show full abstract

Dunleavy, K., Pittaluga, S., Maeda, L.S., Advani, R., Chen, C.C., Hessler, J., Steinberg, S.M., Grant, C., Wright, G., Varma, G., Staudt, L.M., Jaffe, E.S. & Wilson, W.H. (2013) Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. New England Journal of Medicine, 368, 1408–1416. Evens, A.M., Kanakry, J.A., Sehn, L.H., Kritharis, A., Feldman, T., Kroll, A., Gascoyne, R.D., Abramson, J.S., Petrich, A.M., Hernandez-Ilizaliturri, F.J., Al-Mansour, Z., Adeimy, C., Hemminger, J., Bartlett, N.L., Mato, A., Caimi, P.F., Advani, R.H., Klein, A.K., Nabhan, C., Smith, S.M., Fabregas, J.C., Lossos, I.S., Press, O.W., Fenske, T.S., Friedberg, J.W., Vose, J.M. & Blum, K.A. (2015) Gray zone lymphoma with features intermediate between classical hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort. American journal of hematology., 90, 778–783. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of American Statistical Association, 53, 457–481. Quintanilla-Martinez, L. & Fend, F. (2011) Mediastinal gray zone lymphoma. Haematologica, 96, 496–499. Romaguera, J.E., Fayad, L., Rodriguez, M.A., Broglio, K.R., Hagemeister, F.B., Pro, B., McLaughlin, P., Younes, A., Samaniego, F., Goy, A., Sarris, A.H., Dang, N.H., Wang, M., Beasley, V., Medeiros, L.J., Katz, R.L., Gagneja, H., Samuels, B.I., Smith, T.L. & Cabanillas, F.F. (2005) High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. Journal of Clinical Oncology, 23, 7013–7023. Swerdlow, S., Campo, E., Harris, N., Swerdlow, S., Campo, E. & Harris, N. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon. Traverse-Glehen, A., Pittaluga, S., Gaulard, P., Sorbara, L., Alonso, M.A., Raffeld, M. & Jaffe, E.S. (2005) Mediastinal gray zone lymphoma: the missing link between classic Hodgkin’s lymphoma and mediastinal large B-cell lymphoma. American Journal of Surgical Pathology, 29, 1411–1421. Wilson, W.H., Pittaluga, S., Nicolae, A., Camphausen, K., Shovlin, M., Steinberg, S.M., Roschewski, M., Staudt, L.M., Jaffe, E.S. & Dunleavy, K. (2014) A prospective study of mediastinal gray-zone lymphoma. Blood, 124, 1563–1569.

Keywords: lymphoma; gray zone; zone lymphoma; journal; therapy; cell lymphoma

Journal Title: British Journal of Haematology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.